What's New

Last Posted: Jun 29, 2023

• Telomere Length and Clonal Hematopoiesis.
  George Vassiliou et al. N Engl J Med 2023 5 (26) 2481-2484
• A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms.
  Qiujin Shen et al. Cancer research communications 2023 2(4) 258-276
• Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes.
  Tatsuya Konishi et al. Scientific reports 2023 13(1) 2641
• MDS-287 Genetic Landscape of Somatic Myeloid Mutations in the Presence of Rare TERT Variants and Their Relation to Myeloid Neoplasia.
  Ferrer Alejandro et al. Clinical lymphoma, myeloma & leukemia 2022 22 Suppl 2S309
• A Deep Learning Model for the Automatic Recognition of Aplastic Anemia, Myelodysplastic Syndromes, and Acute Myeloid Leukemia Based on Bone Marrow Smear.
  Wang Meifang et al. Frontiers in oncology 2022 12844978
• TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes.
  Yabe Mariko et al. Cancers 2021 13(21)
• A Geno-Clinical Decision Model for the Diagnosis of Myelodysplastic Syndromes.
  Radakovich Nathan et al. Blood advances 2021
• Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.
  Nazha Aziz et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 JCO2002810
• Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.
  Duncavage Eric J et al. The New England journal of medicine 2021 384(10) 924-935
• GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes.
  Bruzzese Antonella et al. Cancers 2020 Oct 12(10)
• Cyclosporine Broadens the Therapeutic Potential of Lenalidomide in Myeloid Malignancies.
  Dou Aixia et al. Journal of cellular immunology 2020 2(5) 237-244
• Behçet disease (BD) and BD-like clinical phenotypes: NF-kB pathway in mucosal ulcerating diseases.
  Perazzio Sandro F et al. Scandinavian journal of immunology 2020 Sep e12973
• The Evolving Landscape of Myelodysplastic Syndrome Prognostication.
  Shreve Jacob et al. Clinical hematology international 2020 Jun 2(2) 43-48
• Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
  Schratz Kristen E et al. Hematology/oncology clinics of North America 2020 Apr 34(2) 333-356
• Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based survey.
  Pine Alexander B et al. Leukemia & lymphoma 2020 Feb 1-10
• Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?
  Duetz Carolien et al. Current opinion in oncology 2019 Dec
• Genetic predisposition to MDS: diagnosis and management.
  Furutani Elissa et al. Hematology. American Society of Hematology. Education Program 2019 Dec 2019(1) 110-119
• Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence.
  Nazha Aziz et al. JCO precision oncology 2019 3
• Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis.
  Migdady Yazan et al. Clinical lymphoma, myeloma & leukemia 2018 18(8) 528-532
• Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines.
  Bräuninger Andreas et al. The Journal of molecular diagnostics : JMD 2018 20(3) 344-354
• Clinical applicability of proposed algorithm for identifying individuals at risk for hereditary hematologic malignancies.
  Clifford Maggie et al. Leukemia & lymphoma 2019 Jul 1-8
• A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.
  Drusbosky Leylah M et al. Blood advances 2019 Jun 3(12) 1837-1847
• Genetics of MDS.
  Ogawa Seishi et al. Blood 2019 Jan
• The MDS genomics-prognosis symbiosis.
  Nazha Aziz et al. Hematology. American Society of Hematology. Education Program 2018 Nov 2018(1) 270-276
• Current and Future Treatment Options for Myelodysplastic Syndromes: More Than Hypomethylating Agents and Lenalidomide?
  Sockel Katja et al. Drugs 2018 Nov
• Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.
  Bacher Ulrike et al. Blood cancer journal 2018 Nov 8(11) 113
• How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes.
  Steensma David P et al. Blood 2018 Sep
• Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms (CMNs): A Report of the Association for Molecular Pathology.
  McClure Rebecca F et al. The Journal of molecular diagnostics : JMD 2018 Aug
• Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia.
  Tremblay Douglas et al. Oncology (Williston Park, N.Y.) 2018 32(4) e38-e44
• Local Coverage Determination (LCD): Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases (L37606)
  The U.S. Centers for Medicare & Medicaid Services
• Local Coverage Determination (LCD): Flow Cytometry (L33661)
  The U.S. Centers for Medicare & Medicaid Services
• Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
  Hebeda Konnie M et al. Pathobiology : journal of immunopathology, molecular and cellular biology 2018 Jul 1-14
• Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.
  Bartels Stephan et al. Oncotarget 2016 May 7(21) 30084-93
• The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromes.
  Steensma David P et al. Best practice & research. Clinical haematology 2017 Dec 30(4) 295-300
• The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
  Duncavage E J et al. Int J Lab Hematol 2015 May 115-21
• Myelodysplastic syndromes
  From NCATS Genetic and Rare Diseases Information Center